This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Nov. 13, 2013 /PRNewswire/ -- Harwood Feffer LLP (
www.hfesq.com) is investigating potential claims against the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI), concerning whether the board has breached its fiduciary duties to shareholders.